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ABSTRACT
In animal cells, replication-dependent histone pre-
mRNAs are cleaved at the 3′ end by U7 snRNP con-
sisting of two core components: a ∼60-nucleotide U7
snRNA and a ring of seven proteins, with Lsm10 and
Lsm11 replacing the spliceosomal SmD1 and SmD2.
Lsm11 interacts with FLASH and together they re-
cruit the endonuclease CPSF73 and other polyadeny-
lation factors, forming catalytically active holo U7
snRNP. Here, we assembled core U7 snRNP bound to
FLASH from recombinant components and analyzed
its appearance by electron microscopy and ability to
support histone pre-mRNA processing in the pres-
ence of polyadenylation factors from nuclear ex-
tracts. We demonstrate that semi-recombinant holo
U7 snRNP reconstituted in this manner has the same
composition and functional properties as endoge-
nous U7 snRNP, and accurately cleaves histone pre-
mRNAs in a reconstituted in vitro processing reac-
tion. We also demonstrate that the U7-specific Sm
ring assembles efficiently in vitro on a spliceosomal
Sm site but the engineered U7 snRNP is functionally
impaired. This approach offers a unique opportunity
to study the importance of various regions in the Sm
proteins and U7 snRNA in 3′ end processing of his-
tone pre-mRNAs.
INTRODUCTION
Metazoan replication-dependent histone mRNAs are the
only known eukaryotic mRNAs that are not polyadeny-
lated, ending instead with a conserved stem-loop followed
by a short single-stranded tail of 4–5 nucleotides (1,2). They
are formed from longer mRNA precursors (pre-mRNAs)
by a single endonucleolytic cleavage carried out by U7
snRNP, a metazoan-specific minor snRNP that is ∼500-
fold less abundant than the major spliceosomal snRNPs.
Its RNA component, U7 snRNA, is the shortest known
snRNA (∼60 nucleotides) and consists of three functionally
distinct regions (3–6). The 5′ end region of ∼15 nucleotides
base pairs with the sequence in histone pre-mRNA known
as Histone DownstreamElement (HDE). This region is pri-
marily responsible for the substrate specificity ofU7 snRNP
for histone pre-mRNAs. The 9-nucleotide AAUUUGUCU
sequence located immediately downstream of the 5′ end re-
gion is referred to as the Sm binding site (7). This sequence
serves as an assembly site for the unique heptameric Sm ring
of the U7 snRNP in which Lsm10 and Lsm11 replace the
two spliceosomal subunits, SmD1 and SmD2 (8,9). The re-
maining five subunits, SmE, SmF, SmG, SmB and SmD3,
are shared by the two Sm ring types (8,10). The Sm binding
site in U7 snRNA is followed by an extensive 3′ stem-loop
that in vivo may facilitate the assembly of the Sm ring and
protect U7 snRNA against the activity of 3′ exonucleases.
Lsm11 is larger than other proteins of the Sm/Lsm fam-
ily, containing an extended N-terminal region of ∼150
amino acids (9). Residues 20–50 of this region interact with
the N-terminal region of FLASH (11) that self-associates
into a coiled-coil dimer consisting of two parallel  helices
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(12). The heterotrimeric Lsm11/FLASH complex func-
tions as a docking platform for a group of four major
polyadenylation proteins that we refer to as theHistone pre-
mRNA Cleavage Complex (HCC): symplekin, CPSF100,
CPSF73 and CstF64 (13–15). The remaining CPSF sub-
units (CPSF160, WDR33, Fip1 and CPSF30) are detected
in the HCC in substoichiometric amounts. These subunits
form a module that recognizes the AAUAAA sequence in
canonical pre-mRNAs (16–20) and likely represent contam-
inants of U7 snRNP rather than genuine HCC subunits.
Other components of the cleavage and polyadenylation ma-
chinery (21,22), including the two remaining CstF subunits,
are absent.
The recruitment of theHCC convertsU7 snRNP to a cat-
alytically active holo U7 snRNP (14,15). Within the HCC,
CPSF73 contacts the pre-mRNA and functions as the en-
donuclease (23,24). CPSF100 is a homologue of CPSF73
but lacks key residues of the active site (24–26), and sym-
plekin is likely a scaffold that was characterized as a heat
sensitive component of the U7 snRNP (27). RNAi studies
suggest that CstF64 is not required for the function of U7
snRNP in Drosophila (14,28), although it may be essential
for 3′ end processing of histone pre-mRNAs in mammalian
cells (29,30).
In addition to U7 snRNP, 3′ end processing of histone
pre-mRNA requires Stem–Loop Binding Protein (SLBP).
SLBP tightly binds the highly conserved stem-loop struc-
ture located upstream of the HDE (31–33) and contacts a
component of U7 snRNP, likely the FLASH/Lsm11 com-
plex (34), helping to anchor U7 snRNP on histone pre-
mRNA. Substrates that form a strong duplex with the U7
snRNA are processed in mammalian nuclear extracts in the
absence of SLBP (35–37). Following stable binding of the
U7 snRNP to the HDE, histone pre-mRNAs are cleaved
by CPSF73 between the stem-loop and the HDE (23,38),
with the upstream cleavage product representing mature hi-
stone mRNA. The downstream cleavage product contain-
ing the HDE is degraded by the 5′-3′ exonuclease activity of
CPSF73, releasing the U7 snRNP from the base pair inter-
action for the next round of processing (23,39).
In vivo, the spliceosomal Sm ring is assembled from
three pre-formed sub-complexes, SmE/SmF/SmG,
SmD1/SmD2 and SmB/SmD3 (40,41), in a multi-step
process controlled by the Survival of Motor Neurons
(SMN) complex (42–44). The assembly of the U7-specific
Sm ring in vivo is also controlled by the SMN complex,
with the SmD1/SmD2 sub-complex being replaced by
the Lsm10/Lsm11 sub-complex (9,45). The assembly of
the spliceosomal Sm rings was successfully reproduced
in vitro in the absence of the SMN complex using either
endogenous or recombinant components. These studies
generated core U1, U2, U4 and U5 snRNPs suitable for
both structural and functional studies (41,46–50).
Here, we used three recombinant sub-complexes,
SmE/SmF/SmG, SmB/SmD3 and Lsm10/Lsm11, to
assemble the U7-specific Sm ring onto U7 snRNA in vitro.
The resultant core U7 snRNP was bound to bacterially
expressed N-terminal FLASH and incubated with a mouse
nuclear extract to recruit the endogenous HCC. Our
studies show that the semi-recombinant holo U7 snRNP
reconstituted in this manner has the same composition
as U7 snRNP purified from nuclear extracts and is active
in 3′ end processing of histone pre-mRNAs, functionally
mimicking endogenous U7 snRNP. U7 snRNP is limiting
in animal cells and its purification in large quantities and
native state has proven difficult in the past (10). This report
is the first step toward reconstituting holo U7 snRNP
entirely from recombinant components for future detailed
functional and structural studies.
MATERIALS AND METHODS
RNAs
RNAs were generated by T7 transcription from linearized
plasmids or double stranded oligonucleotides containing a
T7 promoter, or synthesized by GEDharmacon (Lafayette,
CO, USA), as listed below. All sequences are written in 5′-
3′ orientation. pc (photo-cleavable linker), m (2′-O-methyl
modification), 18S (18 atom spacer).
- Human U7 snRNA, GE Dharmacon, 63 nucleotides: CA
GUGUUACAGCUCUUUUAGAAUUUGUCUAGU
AGGCUUUCUGGCUUUUUACCGGAAAGCCCCU
- Human U7-5′pcB snRNA, GE Dharmacon, 60 nu-
cleotides: 5′Biotin/pc/18S/18S/AGUGUUACAGCU
CUUUUAGAAUUUGUCUAGUAGGCUUUCUGG
CUUUUUACCGGAAAGCCC
- Mouse U7 snRNA, linearized plasmid, T7 transcription,
76 nucleotides: GGCGAAUUCAAGUGUUACAGCU
CUUUUAGAAUUUGUCUAGCAGGUUUUCUGA
CUUCGGUCGGAAAACCCCUAAGCU
-MouseU7/4BP snRNA, duplexDNA,T7 transcription,
51 nucleotides: GGUGUUACAGCUCUUUUAGAAU
UUGUCUAGCAGGCUGACUUCGGUCGGCCC
- HybU7/4BP snRNA, duplex DNA, T7 transcription,
56 nucleotides: GGCAGAAAAUUUUAUCUCAUUU
AGAAUUUGUCUAGCAGGCUGACUUCGGUCG
GCCC
- SupU7 snRNA, linearized plasmid, T7 transcription, 76
nucleotides: GGCGAAUUCAAGUGUUACAGGAGA
AAUAGAAUUUGUCUAGCAGGUUUUCUGACU
UCGGUCGGAAAACCCCUAAGCU
- SupU7/4BP snRNA, duplex DNA, T7 transcription, 51
nucleotides: GGUGUUACAGGAGAAAUAGAAUUU
GUCUAGCAGGCUGACUUCGGUCGGCCC
- SupU7/SL+5 snRNA (the inserted AUCUG is under-
lined),Dharmacon, 39 nucleotides: AGUGUUACAGGA
GAAAAUCUGUAGAAUUUGUCUAGCAGG
- U7+4 snRNA (the inserted AUCG is under-
lined), linearized plasmid, T7 transcription, 80 nu-
cleotides: GGCGAAUUCAAGUGUUACAGCUCU
UUAUCGUAGAAUUUGUCUAGCAGGUUUUCU
GACUUCGGUCGGAAAACCCCUAAGCU
- SupU7+5N snRNA (the inserted UAGAC is un-
derlined), linearized plasmid, T7 transcription, 81
nucleotides: GGCGAAUUCAAGUGUUACAGGAGA
AAUAGACUAGAAUUUGUCUAGCAGGUUUU
CUGACUUCGGUCGGAAAACCCCUAAGCU
- SupU7-3 snRNA (the inserted AUA is underlined),
linearized plasmid, T7 transcription, 73 nucleotides:
GGCGAAUUCAAGUGUUACAGGAGAAGAAUU
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gkz1148/5670844 by Instytut Biochem
ii i Biofizyki PAN
 user on 12 D
ecem
ber 2019
Nucleic Acids Research, 2019 3
UGUCUAGCAGGUUUUCUGACUUCGGUCGGA
AAACCCCUAAGCU
- Drosophila U7 snRNA, linearized plasmid, T7 transcrip-
tion, 85 nucleotides: GGCGAAUUCAUUGAAAAU
UUUUAUUCUCUUUGAAAUUUGUCUUGGUGG
GACCCUUUGUCUAGGCAUUGAGUGUUCCCG
UUAAGCU
-H2a/Ys pre-mRNA, linearized plasmid, T7 transcription,
107 nucleotides: GGCGAAUUCGAGCUCGGUACCA
AAAAGGCUCUUUUCAGAGCCACCCACUGAA
UCAGAUUUUCUCCUGUGACACUGUAGCCAA
GCCGGAGUAGGCUCGAGUGUAAGCU
- SL/Ys pre-mRNA, linearized plasmid, T7 transcrip-
tion, 80 nucleotides: GGCGAAUUCAGAGCCACCCA
CUGAAUCAGAUUUUCUCCUGUGACACUGUA
GCCAAGCCGGAGUAGGCUCGAGUGUAAGCU
- DCP/Ys RNA, GE Dharmacon, 30 nucleotides: CUGA
AUCAGAUUUUCUCCUGUGACACUGUA
- H2a+4 pre-mRNA (the inserted nucleotides are un-
derlined), linearized plasmid, T7 transcription, 89
nucleotides: GGCGAAUUCGAGCUCGGUACCA
AAAAGGCUCUUUUCAGAGCCACCCACUGAA
UUAAUUCGAUAAAGAGUUGUGUCACGGUAG
CCAAGCU
- H2a+4/Ys pre-mRNA (the inserted nucleotides are
underlined), linearized plasmid, T7 transcription, 89
nucleotides: GGCGAAUUCGAGCUCGGUACCA
AAAAGGCUCUUUUCAGAGCCACCCACUGAA
UUAAUUCGAUUUUCUCUUGUGUCACGGUAG
CCAAGCU
- H2a+12 pre-mRNA (the inserted nucleotides are un-
derlined), linearized plasmid, T7 transcription, 97
nucleotides: GGCGAAUUCGAGCUCGGUACCA
AAAAGGCUCUUUUCAGAGCCACCCACUGAA
UUGACCCACCAAUUCGAUAAAGAGUUGUGU
CACGGUAGCCAAGCU
- H2a+12/Ys pre-mRNA (the inserted nucleotides are
underlined), linearized plasmid, T7 transcription, 97
nucleotides: GGCGAAUUCGAGCUCGGUACCA
AAAAGGCUCUUUUCAGAGCCACCCACUGAA
UUGACCCACCAAUUCGAUUUUCUCUUGUGU
CACGGUAGCCAAGCU
- H2a WT/Ys pre-mRNA, linearized plasmid, T7 tran-
scription, 85 nucleotides: GGCGAAUUCGAGCUCG
GUACCAAAAAGGCUCUUUUCAGAGCCACCC
ACUGAAUUCGAUUUUCUCUUGUGUCACGGU
AGCCAAGCU
- SupU7, GEDharmacon, 18 nucleotides: mCmUmAmU
mUmUmCmUmCmCmUmGmUmAmAmCmAmC
Other RNAs and oligonucleotides were described:
mH2a/5m-5′pcB, mH2a/2m-3′B and dH3/2m-3′B, re-
ferred previously to as 5′pcB-mH2a/5m, 3′B-mH2a/2m
and 3′B-dH3/2m, respectively) pre-mRNAs (15), SL RNA
(51), oligonucleotides complementary to the 5′ end of
human/mouse U7 snRNA (34).
Antibodies
Antibodies against human SLBP, Lsm11 and FLASH
were described previously (11,52,53). Antibodies recogniz-
ing mouse CPSF100 (A301-581A), CPSF73 (A301-091A)
and CstF64 (A301-092A) were from Bethyl Laboratories
(Montgomery, TX). Anti-symplekin (610644) was from BD
Biosciences. Antibodies against SmB and SmD3 were from
Sigma and Bethyl Laboratories (Montgomery, TX), respec-
tively. Anti-MBP was from New England Biolabs and anti-
GST was kindly provided by the Strahl laboratory (UNC
Chapel Hill). All primary antibodies were used in 1:2000
dilution.
Cell culture and nuclear extract preparation
Mousemyeloma cells were grown byCell Culture Company
(Minneapolis,MN,USA), shipped onwet ice as a soft pellet
and used to prepare nuclear extract the following day, as
described (15,54).
RNA labeling and in vitro processing
T7-generated histone pre-mRNAs were treated with calf in-
testinal phosphatase (New England Biolabs) to remove the
5′ triphosphate and labeled at the 5′ end with 32P using T4
polynucleotide kinase (New England Biolabs), as described
(37). Synthetic histone pre-mRNAs were labeled at the 5′
end without prior phosphatase treatment. Processing of ra-
dioactively labeled histone pre-mRNAs in mouse nuclear
extracts was carried out as described (55,56).
Expression and purification of His–Lsm11/MBP–Lsm10
complex
The construct for N-terminal 6xHis-tagged Lsm11 either
containing or lacking the internal loop (residues 211–332)
was cloned into the baculovirus pFL vector (57) under the
control of a PH promoter. N-terminal maltose binding pro-
tein (MBP)-tagged Lsm10 was cloned into the same vector
under the control of a P10 promoter. Both proteins were
co-expressed in Hi5 insect cells using the baculovirus ex-
pression system. Cells were harvested 48 h post infection,
collected by centrifugation, re-suspended in lysis buffer (20
mMTris pH 7.5, 500mMNaCl, 10mM imidazole, 5% glyc-
erol, SIGMAFAST™ Protease Inhibitor Cocktail, 10 mM
-mercaptoethanol), and lysed by sonication. Cell lysate
was centrifuged at 25 000 × g for 40 min at 4◦C and the su-
pernatant incubated with nickel beads for 1 h and loaded
onto a gravity flow column (Bio-Rad) for affinity purifi-
cation. The nickel beads were washed with a buffer con-
taining 20 mM Tris pH 7.5, 500 mM NaCl, 40 mM imi-
dazole, and 10 mM -mercaptoethanol. The protein was
eluted with a buffer containing 20 mM Tris pH 7.5, 500
mM NaCl, 500 mM imidazole, 5% glycerol, and 10 mM -
mercaptoethanol. The eluate was diluted 2.5 times with a
buffer containing 20 mM HEPES pH 7.5 and 5 mM DTT
before being loaded onto a HiTrap Heparin column (GE
Healthcare), and the protein complex was eluted with a
salt gradient starting with 80% Buffer A (20 mM HEPES
pH 7.5, 5 mM DTT) and 20% Buffer B (20 mM HEPES
(pH 7.5), 1 M NaCl, 5 mM DTT) to 100% Buffer B. Rel-
evant fractions were pooled and the protein concentrated
and stored at −80◦C.
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Expression and purification of His-SmD3/SmB complex
N-terminal 6xHis-tagged SmD3 was cloned into pET28a
(Novagen), while untagged full length SmB and SmB en-
compassing residues 1–95 were cloned into pCDFDuet
MCS2. Both genes were co-expressed in Escherichia coli
BL21 Star (DE3) strain (Novagen) for 18 h at 20◦C.
Cells were harvested by centrifugation, re-suspended in ly-
sis buffer (20 mM Tris pH 7.5, 500 mM NaCl, 10 mM
imidazole, 5% glycerol, 17.8 g/ml PMSF, 10 mM -
mercaptoethanol) and purified using nickel affinity, as de-
scribed above. The eluted protein was further purified by
heparin affinity using a gradient of Buffer A (20 mM
HEPES pH 7.5, 5 mMDTT) and Buffer B (20 mMHEPES
pH 7.5, 1 MNaCl, 5 mMDTT) starting with 40% Buffer B
to 100% Buffer B. The purified complex was concentrated
and stored at −80◦C.
Expression and purification of SmG-His/SmE/SmF com-
plex
C-terminal 6xHis-tagged SmG was cloned into pET26b,
while untagged SmE and SmFwere cloned into pCDFDuet
MCS1 and MCS2, respectively. All three proteins were co-
expressed in E. coli BL21 Star (DE3) strain (Novagen) and
purified as described above for the 6xHis-SmD3/SmB com-
plex.
Specimen preparation for electron microscopy and data col-
lection
Equimolar amounts of 6xHis-Lsm11(211–332)/MBP-
Lsm10, His-SmD3/SmB(1–95), SmG-His/SmE/SmF, U7
snRNA (nucleotides 20–63) and two molar equivalent of
FLASH (51–137) C54S/C83A double mutant were mixed
in an assembly buffer containing 20 mM HEPES pH 7.5,
250 mM NaCl, 5 mM MgCl2 and 5 mM DTT. Prior to
mixing, the RNA was heated at 90◦C for 5 min and snap
cooled on ice for 10 min. The mixture of all the above com-
ponents was incubated at 30◦C for 30 min, followed by an
incubation at 37◦C for 15 min (58), then cooled on ice for
10 min and incubated overnight at 4◦C with TEV protease
to remove the MBP tag from Lsm10. The complex was pu-
rified by size exclusion chromatography using a Superdex
200 column (GEHealthcare) in the following buffer: 20mM
HEPES pH 7.5, 400 mM NaCl, 1.5 mMMgCl2 and 5 mM
DTT. Fractions from size exclusion chromatography were
analyzed by electrophoresis in 18% SDS/polyacrylamide
gels and Coomassie blue staining. Purified samples of the
U7 snRNP-FLASH complex were stained using 2% uranyl
acetate on a continuous carbon grid and examined by neg-
ative stain electron microscopy. Several images were taken
using an FEI TF20 transmission electron microscope to de-
termine sample quality. For cryo-electron microscopy, the
grids were prepared using an FEI Vitrobot Mark IV set
at 4◦C and 100% humidity. A sample (3 l) was applied
onto a glow-discharged Quantifoil 300 mesh 1.2/1.3 cop-
per grid, incubated for 10 s and blotted for 5.5 s with a blot
force of −3. After blotting, a 0.5 s wait time was applied
before the sample was plunge-frozen in liquid ethane. For
cryo-EM data, 1135 stacks of images were collected on a
Titan Krios equipped with a Volta Phase Plate at the New
York Structural Biology Center. The images were recorded
with a K2 Summit Camera using the counting mode at a
nominal magnification of 29 000× (pixel size = 0.85 A˚) at
a fixed defocus of −0.33 m. For each image, a total expo-
sure time of 6 s was recorded in 30 frames with a dose rate
of 42 e–/A˚2. The images were motion corrected and dose-
weighted using MotionCor2 (59). Initially, 520 499 parti-
cles were selected using Gautomatch (www.mrc-lmb.cam.
ac.uk/kzhang/Gautomatch/). The particles were windowed
into 144 × 144 pixel boxes. CTF parameters were deter-
mined using CTFFIND4 (60). Several rounds of 2D clas-
sification were performed using Relion 3.0 (61) to select for
good quality particles.
In vitro assembly of core U7 snRNP for functional studies
The assembly of core U7 snRNP for functional studies was
carried out in a high salt assembly buffer containing 600
mMKCl, 15 mMHEPES pH 7.9, 15% glycerol, 0.25 g/l
yeast tRNA and 20 mMEDTA. In some experiments, SmB
contained only the N-terminal region encompassing amino
acids 1–95, and Lsm11 lacked a large loop (amino acids
211–332) that separates Smmotifs 1 and 2. CoreU7 snRNP
was assembled in a final volume of 100 l containing 75 l
of the assembly buffer and each component at 20 M. If
necessary, the assembly reaction was appropriately scaled
up, maintaining each component at 20 M. Lsm10/Lsm11
and SmE/SmF/SmG sub-complexes were first mixed in the
assembly buffer with U7 snRNA and incubated together at
32◦C for 90 min. The assembly reaction was subsequently
supplementedwith the remaining SmB/SmD3 sub-complex
and incubated at 32◦C for additional 90min. The assembled
core U7 snRNP was separated from the unbound compo-
nents by size exclusion chromatography (SEC) using Super-
ose™ 6 Increase 3.2/300 gel filtration column (GE Health-
care) and a buffer compatible with in vitro 3′ end process-
ing reaction: 75 mM KCl, 15 mM HEPES–KOH pH 7.9,
10% glycerol and 20mMEDTApH8. In some experiments,
coreU7 snRNPprior to purifying by SECwas pre-bound to
FLASH (40 M, 2-fold molar excess compared to the core
U7 snRNP). When indicated, SEC step was omitted and
the core U7 snRNP either alone or pre-bound to FLASH
was directly purified by binding to histone pre-mRNA con-
taining biotin at the 5′ or 3′ end, and immobilized on strep-
tavidin beads for subsequent incubation with mouse nu-
clear extract and reconstitution of semi-recombinant holo
U7 snRNP.
Purification of processing complexes containing semi-
recombinant holo U7 snRNP
Core U7 snRNP/FLASH complex (approximately 100
pmol) was mixed in 1 ml of processing buffer (75 mMKCl,
15 mM HEPES–KOH pH 7.9, 15% glycerol and 20 mM
EDTA pH 8) with equimolar amounts of SLBP and his-
tone pre-mRNA containing biotin at the 5′ or 3′ end and
spun down at 4◦C in a microcentrifuge (10 000 × g for 10
min) to remove potential precipitates. The supernatant was
loaded over 30–40 l of streptavidin beads and rotated for 1
h at 4◦C to immobilize histone pre-mRNAbound to recom-
binant core U7 snRNP. The beads were gently spun down
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in a microcentrifuge (3 min at 30 × g), rinsed three times
with processing buffer and rotated with 1 ml of the same
buffer for 1 h and next transferred to a new tube for an ad-
ditional 1 h rotationwith a fresh change of buffer. The beads
were subsequently incubated with 1 ml of a mouse nuclear
extract that prior to using was supplemented with 80 mM
EDTA to a final concentration of 20 mM and spun down at
4◦C in a microcentrifuge (10 000 × g for 10 min) to remove
precipitates. Following 1 h rotation at 4◦C with the pre-
cleared nuclear extract, the beads containing immobilized
complexes of histone pre-mRNA and semi-recombinant
holo U7 snRNP were gently spun down and exhaustively
washed, including one tube change, as described above. Pro-
cessing complexes assembled onmH2a/2m-3′B pre-mRNA
were eluted to solution by boiling in SDS sample buffer, sep-
arated by electrophoresis in a 4–12% SDS/polyacrylamide
gel and analyzed by silver staining and/or western blotting.
Processing complexes assembled on mH2a/5m-5′pcB pre-
mRNA were UV eluted in 50 l of processing buffer and
were analyzed by Western blotting, silver staining and/or
mass spectrometry, as described (15,62).
Purification of semi-recombinant holo U7 snRNP assembled
on U7-5′pcB snRNA
A complex (∼100 pmol) of core U7 snRNP assembled on
U7–5′pcB snRNA and bound to FLASHwas added to 1ml
of processing buffer (see above) and directly immobilized on
30–40 l of streptavidin beads and extensively washed with
the same buffer, as described above. The beads were rotated
with 1 ml of a pre-cleared mouse nuclear extract contain-
ing 20 mM EDTA to reconstitute holo U7 snRNP. Follow-
ing a 1 h rotation with the extract at 4◦C, the beads were
collected by a gentle spin in a microcentrifuge (3 min at 30
× g) and extensively washed with processing buffer, as de-
scribed above. Semi-recombinant holo U7 snRNP was re-
leased to solution by irradiating a suspension of the beads
in processing buffer (75 l) with long wave UV, as described
(15,62). To determine the composition of semi-recombinant
holo U7 snRNP, a fraction of the UV eluted solution (10%)
was analyzed by Western blotting, silver staining and/or
mass spectrometry. Processing activity of semi-recombinant
holo U7 snRNP was tested using 0.025 pmol (0.5 ng) of 5′-
labeled pre-mRNA substrate. Varying amounts of the UV
eluted solution (0.5–5%) were added with or without 10
pmol of SLBP to 7.5 l of the assembly buffer containing
pre-mRNA substrate and 0.25 g/l yeast tRNA (Invitro-
gen). The reaction samples were incubated 60 min at 32◦C,
treated with proteinase K for 1 h and mixed with 4 volumes
of 8M urea dye. Radioactive RNAs were separated by elec-
trophoresis in 8% polyacrylamide/7M urea denaturing gels
and detected by autoradiography.
Cleavage activity of complexes immobilized on streptavidin
beads
mH2a/2m-3′B pre-mRNA labeled at the 5′ end with 32P
(∼100 ng or 5 pmol, 50 000 counts per minute) was mixed
in 1 ml of processing buffer with 10 pmol of FLAG-tagged
full length SLBP and 100 pmol of core U7 snRNP bound
to either N139 or 61 FLASH. Following a 5 min incu-
bation on ice, the samples were spun down in a microcen-
trifuge (10 min at 10 000 × g) to remove potential precip-
itates and the supernatant was rotated with 30–40 l of
streptavidin beads for 1 h at 4◦C to bind processing com-
plexes via biotin attached to the 3′ end of mH2a/2m-3′B
pre-mRNA. The beads were gently spun down (3 min at
30 × g), washed by rotating with processing buffer for 1 h
at 4◦C, transferred to a fresh tube and rotated in the same
buffer for an additional hour. Mouse nuclear extract (250
l) containing 20mMEDTAwasmixed with 750l of pro-
cessing buffer, cleared by spinning in a microcentrifuge (10
min at 10 000 × g) and loaded over the extensively washed
streptavidin beads containing immobilized complexes. The
samples were rotated for 1 h at 4◦C to reconstitute holo U7
snRNP, gently spun down and extensively washed using two
changes of processing buffer, as described above. One half
of the beads was re-suspended in SDS sample buffer and
the bound proteins separated by electrophoresis in a 4–12%
SDS/polyacrylamide gel and analyzed by western blotting
or silver staining. The remaining half of the beads was re-
suspended in processing buffer, divided in small aliquots
and left on ice or rotated at 32◦C for 90 min to evaluate
processing activity. The RNAwas recovered from the beads
by boiling for 5 min in the presence of 2% SDS and 0.3
M sodium acetate, phenol extraction and ethanol precip-
itation. The precipitated RNA was separated by gel elec-
trophoresis in 8%/7 M urea gel and detected by autoradio-
graphy.
Direct analysis of processing activity of recombinant core U7
snRNPs in nuclear extracts
Recombinant core U7 snRNPs assembled on U7 snRNA
with wild type mouse/human 5′ region (thus having
the same substrate specificity as endogenous mouse U7
snRNA) prior to adding to a mouse nuclear extract were
bound to histone pre-mRNA. This pre-binding step mini-
mized the contribution of endogenous U7 snRNP to pro-
cessing. Approximately 1 pmol of recombinant core U7
snRNP was mixed with 7.5 l of processing buffer and
0.025 pmol of radioactive substrate, incubated on ice for
5 min and the complex added to 7.5 l of a mouse nu-
clear extract containing 20 mM EDTA. Our titration ex-
periments demonstrated that this amount of nuclear ex-
tract contains sufficient amounts of free HCC to assemble 1
pmol of core U7 snRNP into fully active semi-recombinant
holo U7 snRNP. Recombinant core U7 snRNPs assembled
on U7 snRNA that contained altered 5′ region, including
SupU7, HybU7 andDmU7 (thus having different substrate
specificity than endogenous mouse U7 snRNA), were di-
rectly added to the nuclear extract and tested for processing
activity with their respective substrates. The reaction sam-
ples were incubated for 60 min at 32◦C and the radioactive
RNA was analyzed, as described above.
RESULTS
Assembly and electron microscopy studies of the core U7
snRNP/FLASH complex
The seven proteins of the U7 ring were expressed as three
sub-complexes. His-Lsm11(211–332) and MBP-Lsm10
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were expressed in baculovirus-infected insect cells from a
single vector under the control of two separate promot-
ers. Lsm11 lacked amino acids 211–332 that encompass a
large loop between Sm1 and Sm2 motifs, and Lsm10 was
full length and fused to maltose binding protein (MBP) to
enhance solubility. Expression of this complex in E. coli
was unsuccessful. An SmG-His/SmE/SmF ternary com-
plex and a His-SmD3/SmB(1–95) binary complex were ex-
pressed in E. coli. SmB lacked the unstructured C-terminal
region located between amino acids 96 and 231 that was
likely to affect alignment of the U7 snRNP particles in elec-
tron microscopy.
To generate the core U7 snRNP/FLASH complex for
electron microscopy studies, the three sub-complexes were
mixed together with a truncated version of human U7
snRNA (nucleotides 20–63) and the C54S/C83A double
mutant of theN-terminal fragment of FLASH (amino acids
51–137) expressed inE. coli (12). TheMBP tagwas removed
by proteolysis, and the complex was purified by size exclu-
sion chromatography (SEC), eluting as a single peak from
the column (Figure 1A). SDS-PAGE analysis of the peak
fraction showed that it contained all eight proteins of the
core U7 snRNP/FLASH complex (Figure 1A).
We first carried out negative-stain electron microscopy
(EM) to assess the quality and suitability of the purified
U7 snRNP/FLASH complex for cryo-electron microscopy
(cryo-EM) studies. Negative-stain images of the complex
showed the presence of ring-shaped particles with a diam-
eter of ∼80 A˚ (Figure 1B), resembling the shape of core
U4 snRNP that shares five out of seven Sm subunits with
U7 snRNP (48). To obtain a higher resolution visualization
of the U7 snRNP/FLASH complex, we carried out cryo-
EM studies (Figure 1C) using a Volta phase plate because
of the relatively small size of the particles. 2D class averag-
ing yielded objects resembling a donut with an attached tail
(Figure 1D), which based on the U4 snRNP structure likely
represent the Sm ring of the U7 snRNP and the stem-loop
of the U7 snRNA, respectively. However, the small size of
the particles and the pseudo-symmetry of the Sm ring pre-
cluded us from locating FLASH and obtaining a meaning-
ful 3D reconstruction.
Composition of semi-recombinant holo U7 snRNP
For functional studies, core U7 snRNPwas assembled from
the three sub-complexes described above. Lsm11 was either
full length or lacked amino acids 211–332. In most exper-
iments, SmB contained only the first 95 amino acids. The
MBP tag fused to Lsm10 did not interfere with the process-
ing activity of U7 snRNP (data not shown) and was not
removed by proteolysis. The remaining proteins of the Sm
ring were full length. Initially, for the assembly of core U7
snRNP we used chemically synthesized 63-nucleotide hu-
manU7 snRNA (Figure 2A). The three sub-complexes were
mixed in a high salt buffer with equimolar amounts of the
synthetic U7 snRNA and the assembled core U7 snRNP
was bound to the N-terminal fragment of FLASH via its
interaction with Lsm11 and purified by SEC. Depending
on the experiment, we used FLASH encompassing amino
acids 1–139 (139N) or its truncated forms lacking the first
51 (51) or 61 (61) residues, with each protein being N-
terminally fused to either a 6xHis or GST tag. The in vitro
assembled and purified complex of core U7 snRNP and
FLASH was next incubated with a mouse nuclear extract
to bind endogenous HCC and evaluated for processing ac-
tivity using appropriate histone pre-mRNA substrates.
We first tested whether an in vitro assembled complex of
core U7 snRNP (full length Lsm11 and SmB 1–95) and
GST tagged 139N FLASH bound to histone pre-mRNA
is capable of recruiting the HCC. An aliquot of the core
U7 snRNP/FLASH (50 pmol) was bound in the pres-
ence of full length SLBP/FLAG (50 pmol) to 25 pmol
of mH2a/2m-3′B pre-mRNA that contained biotin at the
3′ end (Figure 2A) (15,34). The molar excess of core U7
snRNP/FLASH and SLBP served to convert most of the
substrate into a complex. The interaction of mH2a/2m-3′B
and U7 snRNP is primarily mediated by formation of a
strong 16-base pair duplex between the HDE of the pre-
mRNA and the 5′ end of the U7 snRNA, and SLBP was
added to additionally stabilize this interaction (34). In some
experiments, full length SLBP was replaced by a His-tagged
truncated version (amino acids 125–223) that retains nor-
mal function in processing (34).
The complex containing mH2a/2m-3′B pre-mRNA,
SLBP and the in vitro assembled core U7 snRNP bound
to 139N FLASH was immobilized on streptavidin (SA)
beads and incubated on ice with either a buffer, as a control,
or a mouse nuclear extract to recruit missing polyadeny-
lation factors of the HCC, hence reconstituting a semi-
recombinant holoU7 snRNP.Note thatmH2a/2m-3′Bpre-
mRNA contains two 2′-O-methyl groups immediately up-
stream of the HDE that do not block cleavage but pre-
vent subsequent degradation of the downstream product
and displacement of U7 snRNP from the HDE (Figure
2A) (15,34). Following exhaustive washes, components of
the immobilized complexes were separated on a 4–12%
SDS/polyacrylamide gel and visualized by silver staining.
In both samples, GST-tagged 139NFLASHwas readily de-
tectable, as were the two largest subunits of the recombi-
nant core U7 snRNP: full length Lsm11, and Lsm10 fused
to MBP (Figure 2B, lanes 2 and 4). The complex incubated
in the presence of the nuclear extract (Figure 2B, lane 4),
but not in the presence of the buffer (Figure 2B, lane 2), ad-
ditionally contained a number of bands identified by West-
ern blotting as subunits of the HCC: symplekin, CPSF100,
CPSF73 and CstF64 (Figure 2C). We conclude that the re-
constituted semi-recombinant holoU7 snRNP resembles in
its composition endogenous holo U7 snRNP isolated from
mouse nuclear extracts using the same approach (34). Only
trace amounts of the core U7 snRNP components and two
nonspecific proteins of the extract were bound to SA beads
in the absence of the pre-mRNA (Figure 2B, lanes 1 and
3). Note that mH2a/2m-3′B pre-mRNA and the in vitro as-
sembled core U7 snRNP were pre-bound together prior to
incubation with the extract, preventing purification of en-
dogenous U7 snRNP by the pre-mRNA.
We next assembled and purified semi-recombinant holo
U7 snRNP using mH2a/5m-5′pcB pre-mRNA rather than
mH2a/2m-3′B pre-mRNA (Figure 2D). This substrate con-
tains biotin at the 5′ end followed by a photo-sensitive linker
that facilitates selective elution of the immobilized com-
plexes from SA beads by irradiation with long wave UV
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Figure 1. Reconstitution andEMstudies of coreU7 snRNP. (A)Gel filtration profile of assembled coreU7 snRNP in a complexwith FLASH.The complex
elutes in the first sharp and nearly symmetrical peak (P). A Coomassie blue-stained SDS-PAGE gel of the complex is shown in the insert. (B) Negative-
stain image of the ring-shaped structures of the core U7 snRNP-FLASH complex. (C) Cryo-EM image of the core U7 snRNP-FLASH complex. (D) 2D
classification of the particles in the cryo-EM images. Density for the U7 snRNP Sm ring and possibly the stem-loop of the U7 RNA could be recognized.
39 270 particles were selected from the images and classified.
(366 nm) (15,62). This method yields processing complexes
that lack background proteins nonspecifically bound to SA
beads and are suitable for direct and unbiased mass spec-
trometry analysis. The mH2a/5m-5′pcB substrate contains
five 2′-O-methyl groups around the cleavage site that pre-
vent processing in nuclear extracts, hence increasing the
yield of complete complexes (15). Analysis of a small frac-
tion of the UV-eluted complexes by silver staining (Figure
2E), Western blotting (not shown) and mass spectrometry
(Figure 2F) further confirmed that the semi-recombinant
holo U7 snRNP does not differ in composition from the
endogenous holo U7 snRNP, being associated with sym-
plekin, CPSF100, CPSF73 and CstF64. In the UV-eluted
samples, mass spectrometry also identified the remain-
ing components of CPSF (CPSF160, WDR33, Fip1 and
CPSF30) but silver staining and mass spectrometry sug-
gested they were present in smaller amounts, as previously
demonstrated for endogenous U7 snRNP (15,62). We con-
clude that in vitro assembled core U7 snRNP bound to
FLASH associates in nuclear extracts with the same subset
of polyadenylation factors as the endogenous U7 snRNP.
Processing activity of purified semi-recombinant holo U7
snRNP
We took advantage of the UV-elution method to directly
purify semi-recombinant holoU7 snRNP on SA beads. The
seven recombinant Sm proteins (full length Lsm11, SmB 1–
95) and 51 FLASH (amino acids 52–139, see also Fig-
ure 5A) were bound to chemically synthesized U7–5′pcB
snRNA that contains biotin and a photo-cleavable linker at
the 5′ end (Figure 3A). The resultant complex was immobi-
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Figure 2. Purification of semi-recombinant holo U7 snRNP via biotin-tagged histone pre-mRNA. (A) The experimental outline. The seven proteins
of U7-specific ring were expressed as three sub-complexes and bound, depending on experiment, to either synthetic or T7-generated U7 snRNA. The
in vitro assembled core U7 snRNP was incubated with N-terminal FLASH and the resultant complex bound to mH2a/2m-3′B histone pre-mRNA (or
another biotin-tagged pre-mRNA) and immobilized on streptavidin beads (SA) for subsequent incubation with nuclear extract and reconstitution of semi-
recombinant holo U7 snRNP. (B, C) Analysis of immobilized holo U7 snRNP by silver staining and Western blotting. Core U7 snRNP bound to 139N
FLASH (amino acids 1–139 N-terminally tagged with GST) was incubated with SA beads in the absence or presence of mH2a/2m-3′B histone pre-mRNA
and/or mouse nuclear extract. Immobilized proteins and RNAs were separated by 4–12% SDS/polyacrylamide gel electrophoresis and visualized by silver
staining (panel B) or Western blotting (panel C). Note that only lanes 3 and 4 from panel B are used for Western blotting. Asterisks in panel B indicate
proteins of the nuclear extract that nonspecifically bind to SA beads. (D–F). Semi-recombinant holo U7 snRNPwas immobilized on SA beads as described
in panels A and B with the exception that the recombinant core U7 snRNP was complexed with 51 FLASH (lacking the first 51 amino acids that are
not required for processing and a GST tag) and bound to mH2a/5m-5′pcB pre-mRNA (panel D) instead of mH2a/2m-3′B. Formation of the complex
was facilitated by addition of recombinant SLBP (amino acids 125–223). The immobilized complex was UV eluted and a fraction of solution analyzed by
silver staining (panel E) or mass spectrometry (panel F). Lane 2 contains recombinant core U7 snRNP that was bound to mH2a/5m-5′pcB pre-mRNA
but not incubated with the mouse nuclear extract.
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Figure 3. Processing activity of purified semi-recombinant holoU7 snRNP. (A) Recombinant core U7 snRNP containing full length Lsm11 and SmB/1–
95 was assembled on synthetic U7–5′pcB snRNA tagged at the 5′ end with biotin and a photo-cleavable linker. (B) The assembled core was bound to 51
FLASH, immobilized on SA beads and incubated with mouse nuclear extract to recruit the HCC. The reconstituted semi-recombinant holo U7 snRNP
was eluted to solution by UV irradiation and a fraction (10%) was analyzed by silver staining (lane 1). Silver staining of UV-eluted core U7 snRNP/51
FLASH complex (no incubation with the nuclear extract) is shown in lane 2. Silver staining of UV-eluted U7–5′pcB snRNA (no Sm ring and FLASH)
incubated with the same nuclear extract is shown in lane 3. (C) The same fraction (10%) of the three UV-eluted samples was analyzed bymass spectrometry.
The table lists top scoring components (scores > 500) of semi-recombinant holo U7 snRNP (lane 1 in panel B). (D) Top scoring proteins identified in the
UV-eluted sample of U7–5′pcB snRNA incubated with the nuclear extract (lane 3 in panel B). (E) A fraction (5%) of the UV-eluted samples shown in panel
B were tested for the ability to support processing of mH2a/2m-3′B pre-mRNA either in the absence or in the presence of SLBP and/or an oligonucleotide
blocking mouse U7 snRNA (U7), as indicated at the top of each lane. (F) Processing of mH2a/2m-3′B pre-mRNA in a mouse nuclear extract alone
(lane 1) or in the presence of SLBP, stem–loop RNA (SL) or U7 oligonucleotide, as indicated at the top of each lane. (G) Processing of mH2a/2m-3′B
pre-mRNA by a fraction (0.5%) of the UV-eluted semi-recombinant holo U7 snRNP alone (lane 2) or in the presence of WT SLBP (lane 3), or its mutant
versions unable to support processing (lanes 4–5).
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lized on SA beads and incubated with the nuclear extract to
recruit the HCC. The reconstituted semi-recombinant holo
U7 snRNP was extensively washed on the beads and eluted
into a buffer by exposure to long wave UV (366 nm). In
parallel to purifying the semi-recombinant holoU7 snRNP,
we also UV-eluted two additional samples as controls: U7-
5′pcB snRNA (no recombinant Sm ring) that was incubated
with the same nuclear extract, and core U7 snRNP bound
to 51 FLASH (no incubation with the extract).
The three UV-eluted samples were analyzed by sil-
ver staining (Figure 3B) and mass spectrometry (Fig-
ure 3C and D) to determine their composition. Based
on both assays, semi-recombinant holo U7 snRNP (Fig-
ure 3A, lane 1) contained all recombinant subunits of
the Sm ring, 51 FLASH, endogenous HCC (symplekin,
CPSF100, CPSF73, CstF64) and the remaining CPSF sub-
units (CPSF160, WDR33, Fip1, CPSF30). In addition,
smaller amounts of various RNA binding proteins were
also detected. The same RNA binding proteins were much
more prevalent in the UV-eluted sample prepared by incu-
bating naked U7-5′pcB snRNA (lacking recombinant Sm
ring) in the nuclear extract (Figure 3B, lane 3, Figure 3D).
Thus, the presence of a Sm ring prevents U7 snRNA from
nonspecifically interacting with abundant RNA-binding
proteins of the nuclear extract. The HCC subunits, Lsm11
and Lsm10 were not present, and SmB, SmF, SmE and
SmD3 were only detected as background contaminants
likely as a result of nonspecific binding of the abundant
spliceosomal snRNPs to the beads. The UV-eluted core U7
snRNP that was not incubated with the nuclear extract con-
tained only recombinant proteins used for the assembly:
FLASH and the seven Sm subunits (Figure 3B, lane 2, and
Figure 3C).
A fraction of each UV-eluted solution (5%) was tested
for the ability to cleave 5′ labeledmH2a/2m-3′Bpre-mRNA
(Figure 2A) under standard processing conditions that in-
clude 20mMEDTA.Note that the UV-eluted samples were
free of endogenous U7 snRNP (which lacks the biotin tag)
and the pre-mRNA substrate was not exposed at any point
to the nuclear extract. Of the three UV-eluted samples, only
semi-recombinant holo U7 snRNP cleaved mH2a/2m-3′B
pre-mRNA (Figure 3E, lane 3), and as expected core U7
snRNP and U7 snRNA bound to various hnRNPs and
other RNA binding proteins of the nuclear extract were in-
active (Figure 3E, lanes 7 and 9, respectively). Cleavage me-
diated by purified semi-recombinant holo U7 snRNP oc-
curred at the same site that is selected by endogenous U7
snRNP (Figure 3E, lane 1) and was blocked by MmU7,
an antisense oligonucleotide complementary to the 5′ end
of U7 snRNA (Figure 3E, lane 4). Based on these results
we conclude that the purified semi-recombinant U7 snRNP
contains all components essential for the catalytic activity.
This is the first example of a U7-dependent processing re-
action reconstituted from purified components and carried
out in a buffer rather than in a protein- and RNA-rich en-
vironment of the nuclear extract.
Cleavage was strongly stimulated in the presence of re-
combinant SLBP (Figure 3E, lane 5). mH2a/2m-3′B pre-
mRNA contains an improved HDE that forms with the
U7 snRNA an uninterrupted duplex of 16 base pairs and
processing of this pre-mRNA in mouse nuclear extracts is
SLBP-independent, with pre-binding of endogenous SLBP
by excess stem-loop RNA (SL) or adding recombinant
SLBP having no inhibitory or stimulatory effect, respec-
tively (Figure 3F, compare lane 1 with lanes 3 and 4). The
stimulatory effect of SLBP was even more striking when
smaller amounts of the UV-eluted holo U7 snRNP were
used in the reaction (1% of the sample compared to 5% in
Figure 3E), with processing efficiency shifting from a barely
detectable level in the absence of SLBP to asmuch as 50% in
its presence (Figure 3G, lanes 2 and 3). SLBP mutants con-
taining amino acid substitutions in  helix B of the RNA
Binding Domain (Mut 1) or in the C-terminal region (Mut
2), that fail to interact with native U7 snRNP (34), also
failed to enhance processing activity of the purified semi-
recombinant holo U7 snRNP (Figure 3G, lanes 4 and 5).
Overall, these results demonstrate that the purified semi-
recombinant holo U7 snRNP is catalytically active, accu-
rate in selecting the cleavage site and capable of cooperating
with SLBP in achieving maximum efficiency of processing.
It was possible that the unexpected dependence of the
semi-recombinant holo U7 snRNP on SLBP in cleaving
mH2a/2m-3′B pre-mRNA resulted from deleting the en-
tire unstructured C-terminal region from SmB. Our pre-
vious study suggested that SmB, SmD3 and Lsm10 likely
use their C-terminal regions to bind histone pre-mRNAup-
stream of the HDE, stabilizing the complex between the
substrate and the U7 snRNP (53). We used the UV-elution
method to purify semi-recombinant holo U7 snRNP con-
taining full length Lsm11 and SmB (Supplementary Figure
S1A) but observed no reduction in the dependence of pro-
cessing on SLBP (Supplementary Figure S1B, lanes 4 and
5, Figure S1C, lanes 2 and 3). Note that all ring proteins
in this U7 snRNP were full length, resembling endogenous
U7 snRNP. We also assembled core U7 snRNP in which
Lsm11 lacked the loop sequence and SmB was truncated at
the C-terminus. Semi-recombinant holo U7 snRNP recon-
stituted with these Lsm11 and SmB deletion mutants was
active in processing and depended on SLBP for maximum
activity (Supplementary Figure S2C, lanes 3 and 4). Clearly,
the deleted regions of Lsm11 and SmB play no essential role
in processing in vitro, although they are likely important in
vivo (see Discussion). Unless otherwise indicated, core U7
snRNPs used in all subsequent experiments were assembled
using these Lsm11 and SmB deletion variants. Note that
with this approach, other parts of the Sm proteins, includ-
ing structural and conserved elements in Lsm10 and Lsm11
(63), can be readily scanned for their potential roles in pro-
cessing.
We took advantage of the reconstituted system to test
whether processing activity of UV-eluted semi-recombinant
holo U7 snRNP and its SLBP dependence can be affected
by hnRNPQorCstF64. hnRNPQ is one of relatively abun-
dant RNA binding proteins of the mouse nuclear extract
that we identified by mass spectrometry in a complex with
the 3′ end region of H2a histone pre-mRNA (15,34,53). In
the reconstituted system, this protein and other potential
auxiliary factors are absent, providing a plausible explana-
tion for the strong dependence of the UV-eluted U7 snRNP
on SLBP. CstF64 plays an unclear role in processing of hi-
stone pre-mRNAs but it may be under-represented relative
to the other subunits of endogenous HCC (15,34), result-
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ing in a reduced processing activity of the purified semi-
recombinant holo U7 snRNP in the absence of SLBP. We
expressed hnRNP Q and CstF64 in bacteria (Supplemen-
tary Figure S2A and B) but observed that their addition to
the reconstituted system either alone or together with SLBP
had no detectable effect on processing activity (Supplemen-
tary Figure S2C, lanes 5–8). These results suggest that hn-
RNP Q plays no role in 3′ end processing of histone pre-
mRNAs. Further studies with fully recombinantU7 snRNP
will be required to conclude that CstF64 is a dispensable
component of the HCC.
Altering substrate specificity of semi-recombinant holo U7
snRNP
In addition to using chemically synthesized U7 snRNAs,
we tested the functionality of U7 snRNAs generated by T7
transcription from linearized plasmids or duplex oligonu-
cleotides. Using this approach, we initially generated wild
type mouse U7 snRNA (MmU7) that besides containing a
small number of additional nucleotides at the 5′ and 3′ ends
had the same sequence as endogenous mouse U7 snRNA
(Figure 4A). T7-generated MmU7 snRNA was used to as-
semble core U7 snRNP, bound to 51 FLASH, purified
by SEC and assayed for the ability to support process-
ing. To eliminate the influence of endogenous U7 snRNP,
the purified complex of MmU7 snRNP and 51 FLASH
was pre-bound to the 5′-labeled mH2a/2m-3′B pre-mRNA
and then added to a mouse nuclear extract containing
U7 oligonucleotide. As expected, the oligonucleotide in-
hibited processing of mH2a/2m-3′B pre-mRNA in the ab-
sence of recombinant coreMmU7 snRNP (Figure 4B, com-
pare lanes 2 and 3). Importantly, pre-binding of the sub-
strate to MmU7 snRNP rescued processing activity, alle-
viating the inhibitory effect of the oligonucleotide (Figure
4B, compare lanes 4 and 5). We conclude that T7-generated
U7 snRNA, in spite of containing additional template-
encoded nucleotides at both ends, assembled into a semi-
recombinant U7 snRNP that successfully substituted for
endogenous U7 snRNP.We used T7 transcription to gener-
ate U7 snRNAs in which 4 or 6 base pairs of the stem, or the
entire 3′ terminal stem-loop, were deleted (Figure 4A, 8,
12 or SL, respectively). These truncated U7 snRNAs
reconstituted active semi-recombinant holo U7 snRNP in
the mouse nuclear extract (see below), indicating that the
3′ stem-loop of U7 snRNA is not essential for the in vitro
processing activity of U7 snRNP.
Mutations within the HDE that weaken base pairing
with the U7 snRNA drastically reduce or inhibit process-
ing (37,64,65).We generatedH2a/Ys pre-mRNAby replac-
ing the AAAGAG purine core in 107-nucleotide H2a/max
pre-mRNA with UUUCUC, lowering the number of unin-
terrupted base pairs that are formed with endogenous U7
snRNA from 15 to 9 (Figure 4C). As a result of this mu-
tation, H2a/Ys pre-mRNA was only weakly processed in a
mouse nuclear extract, yielding less than 5% of the cleavage
product during 60 min incubation at 32◦C (Figure 4D, lane
2). In parallel, we generated suppressor (Sup) U7 snRNA
in which the CUCUUU sequence that base pairs with the
purine core of the HDE was replaced with GAGAAA (Fig-
ure 4A). This compensatory mutation restores the 15-base
pair duplex with H2a/Ys pre-mRNA. A fraction of the
SEC-purified complex of core SupU7 snRNP and 51
FLASH added to the nuclear extract strongly stimulated
processing of H2a/Ys pre-mRNAs, increasing the amount
of the cleavage product to ∼80% (Figure 4D, lane 3). This
result clearly demonstrates that HDE mutations are effi-
ciently suppressed by semi-recombinant holo U7 snRNP
assembled on in vitro generated U7 snRNA. Note that in
these and subsequent experiments the influence of endoge-
nous U7 snRNP was nearly eliminated. As a result, the re-
combinant core U7 snRNPs can be added to the nuclear
extract together with the mutant substrate (no pre-binding
required) to form holo U7 snRNP and carry out the cleav-
age reaction.
The residual processing of H2a/Ys pre-mRNA in the
mouse nuclear extract is likely due to the presence of SLBP,
which stabilizes binding of endogenous U7 snRNP to the
mutated HDE in H2a/Ys pre-mRNA (Figure 4D, lane
2, and Figure 4E, lane 1). Consistently, no processing of
H2a/Ys pre-mRNA was observed in the presence of excess
SL RNA that sequesters free SLBP in the extract (Figure
4E, lane 2). The same amount of SL RNA only partially
inhibited processing observed in the presence of recombi-
nant core SupU7 snRNP, by selectively eliminating the ac-
tivity contributed by endogenous U7 snRNP (Figure 4E,
compare lanes 2 and 3). The remaining activity contributed
by SupU7 snRNP, which forms a 15-base pair duplex with
H2a/Ys pre-mRNA, was SLBP-independent. This result
argues against the possibility that semi-recombinant holo
U7 snRNPs are intrinsically defective and unable to effi-
ciently function without SLBP, as suggested by the behavior
of the UV-elutedU7 snRNP incubated with substrate in the
absence of any other protein.
We deleted the stem–loop fromH2a/Ys pre-mRNA, gen-
erating SL/Ys pre-mRNA (Figure 4C). Instead of the
stem-loop, SL/Ys pre-mRNA contains an unstructured
sequence of 20 nucleotides, with the ACCCA sequence
that precedes the cleavage site being unchanged. This sub-
strate does not bind SLBP and in contrast to H2a/Ys is
not cleaved by endogenous U7 snRNP (Figure 4F, lane 2).
Processing was rescued in the presence of the core SupU7
snRNP/51 FLASH complex (Figure 4F, lane 3), further
confirming that semi-recombinant U7 snRNPwith a strong
complementarity to the HDE when tested in the extract
rather than in a reconstituted processing reaction is capa-
ble of efficiently cleaving histone pre-mRNA in the absence
of SLBP.
In addition to endonucleolytically cleaving histone pre-
mRNAs, U7 snRNP also catalyzes 5′-3′ exonucleolytic
degradation of the downstream cleavage product (DCP), re-
leasing U7 snRNA from the base pairing interaction with
the HDE for the next round of processing (23,39). Both
enzymatic activities are provided by CPSF73 (23,66). We
tested 5′-3′ exonucleolytic activity of SupU7 snRNP using
DCP/Ys RNA, a substrate that corresponds to the DCP of
H2a/Ys and SL/Ys pre-mRNAs (Figure 4C). A 60-min
incubation of the 30-nucleotide DCP/Ys in the mouse nu-
clear extract yielded only a small amount of labeled CMP
(Figure 4G, lane 2), an indication of a low level of 5′-3′
degradation by endogenous U7 snRNP. In the presence of
semi-recombinant holo SupU7 snRNP, the degradation ef-
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Figure 4. Altering substrate specificity of semi-recombinant holo U7 snRNP. (A) Sequence and structural organization of mouse U7 snRNA. The CU-
CUUU pyrimidine core of mouse (Mm) U7 snRNA and the nucleotide substitution (lower case letters) in the suppressor U7 snRNA (SupU7) are un-
derlined. Deletions within the 3′ terminal stem-loop are indicated with double-headed arrows. (B) Processing of mH2a/2m-3′B pre-mRNA in a mouse
nuclear extract (NE) alone or in the presence of an oligonucleotide blocking U7 snRNA (U7) and/or recombinant core MmU7 snRNP. Lane 1 contains
mH2a/2m-3′B pre-mRNA alone. (C) Changing six purines in an improvedHDE ofH2a histone pre-mRNA (maxHDE) to six complementary pyrimidines
(Ys, indicated with lower case letters) reduces the number of base pairs formed with endogenous U7 snRNA from 16 to 10 (underlined in the sequence).
The three RNA substrates share the same mutated HDE but differ at 5′ end, with H2a/Ys containing normal stem-loop, SL containing a 20-nucleotide
unstructured region instead of the stem-loop, and DCP/Ys beginning immediately downstream of the cleavage site. Asterisks indicate the position of 32P
label. (D–G) Processing of the mutant RNA substrates shown in panel C in a mouse nuclear extract (NE) alone or in the presence of SupU7 snRNP.
(H). Base pairing potential between Drosophila-specific dH3/2m-3′B pre-mRNA and MmU7 or HybU7 snRNAs. Watson-Crick and G-U base pairs are
represented by vertical lines and dots, respectively. The purine core of DrosophilaHDE is underlined. (I). Processing of dH3/2m-3′B pre-mRNA in a Mm
NE alone or in the presence of indicated semi-recombinant U7 snRNPs.
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ficiency reached 90% (Figure 4G, lane 3). We also tested
the activity of semi-recombinant U7 snRNPs assembled on
SupU7/8 and SupU7/12 snRNAs lacking 4 and 6 base
pairs in the 3′ terminal stem, respectively. The two recon-
stituted semi-recombinant holo U7 snRNPs promoted ef-
ficient degradation of DCP/Ys RNA in a mouse nuclear
extract (Supplementary Figure S3).
The HDEs of all five Drosophila histone pre-mRNAs
are AU-rich and have a limited potential to base pair
with mammalian U7 snRNAs (51,55). dH3/2m-3′B pre-
mRNA contains the HDE from Drosophila histone H3
pre-mRNA (14,34) and may form with mouse U7 snRNA
eleven, mostly AU and GU, base pairs that are interrupted
by a number of mismatches (Figure 4H). As a result of
this poor complementarity, dH3/2m-3′B pre-mRNA is not
cleaved in mouse nuclear extracts (Figure 4I, lane 2). We
tested whether this deficiency can be reversed by replac-
ing the 5′ region in mouse U7/8 and U7/12 snRNAs
(Figure 4A) with a 19-nucleotide sequence complementary
to the HDE of dH3/2m-3′B pre-mRNA (Figure 4H). In-
cluding the two template-encoded guanosines added dur-
ing T7 transcription, the 5′ end of the two new snRNAs,
HybU7/8 and HybU7/12, forms 21 continuous base
pairs with dH3/2m-3′B pre-mRNA (Figure 4H). Impor-
tantly, core HybU7/8 and HybU7/SL snRNPs com-
plexed with 51 FLASH and added to a mouse nuclear
extract where it bound the HCC efficiently cleaved the sub-
strate during a 60 min incubation at 32◦C (Figure 4I, lanes
3 and 4).
As expected, coreHybU7/SL snRNP cleaved dH3/2m-
3′B pre-mRNA only when added to a mouse nuclear ex-
tract; in Drosophila Kc nuclear extract it strongly inhibited
processing (Supplementary Figure S4A, lane 2). This domi-
nant negative effect is likely a result of the efficient base pair-
ing of the HybU7/8 snRNA to dH3/2m-3′B pre-mRNA
and the inability of mammalian Lsm11 and FLASH to re-
cruit Drosophila HCC required for forming a productive
semi-recombinant holo U7 snRNP.
The semi-recombinant holo U7 snRNP assembled in a
mouse nuclear extract on U7 snRNA containing the entire
sequence of Drosophila U7 snRNA (DmU7 snRNA) also
cleaved dH3/2m-3′B pre-mRNA, although the activity was
relatively low (Supplementary Figure S4B, lane 4). The 71-
nucleotideDrosophilaU7 snRNA is∼10 nucleotides longer
than other known U7 snRNAs and contains uridine rather
than adenosine near the end of the Sm site (67). Previ-
ous studies in Xenopus oocytes suggested this adenosine
may be important for the function of U7 snRNP in ver-
tebrates (68), potentially explaining the weak activity of
DmU7 snRNP in the mouse nuclear extract. Interestingly,
this semi-recombinant holo U7 snRNP cleaved dH3/2m-
3′B pre-mRNA5 nucleotides after the stem-loop, thus func-
tionally resembling endogenous mouse U7 snRNP rather
than DrosophilaU7 snRNP, which cleaves 4 nucleotides af-
ter the stem-loop (Supplementary Figure S4B, lanes 3–5).
Thus, the strong tendency of theDrosophila processing ma-
chinery to cleave histone pre-mRNAs closer to the stem-
loop is not dictated by particular features of the Drosophila
U7 snRNA but likely results from the absolute dependence
ofDrosophilaU7 snRNP on SLBP and other aspects of the
Drosophila processing complex (34,51).
The role of FLASH in endonucleolytic cleavage and 5′-3′ ex-
onucleolytic degradation by U7 snRNP
A key role in stably recruiting the HCC by the
FLASH/Lsm11 complex is played by the LDLY mo-
tif located in FLASH between amino acids 55–58 (13,56)
(Figure 5A). FLASH mutants lacking this motif are
inactive in endonucleolytic cleavage, converting U7 snRNP
into a dominant negative factor that binds to histone
pre-mRNA via U7 snRNA but fails to recruit the HCC,
including the CPSF73 endonuclease (56). Surprisingly,
this dominant negative effect was not observed in the
5′-3′ degradation assay, suggesting that in the absence
of functional FLASH the HCC can transiently associate
with U7 snRNP to act as a 5′-3′ exonuclease but not
as an endonuclease (56). Now, with the availability of
recombinant core U7 snRNP that can be associated in vitro
with FLASH of choice, we reinvestigated this surprising
difference between the two reactions in a more controlled
way.
We first analyzed the role of FLASH in reconstitution of
semi-recombinant holo U7 snRNP by immobilizing pro-
cessing complexes on SA beads via mH2a/2m-3′B pre-
mRNA, as illustrated in Figure 1A. Based on both silver
staining (Figure 5B, lane 2) and mass spectrometry (not
shown), pre-binding of recombinant core U7 snRNP to
51 FLASH resulted in an efficient recruitment of sym-
plekin, CPSF100, CPSF73 and CstF64 to the complex.
Only a small amount of theseHCC subunits associatedwith
the core U7 snRNP in the absence of51 FLASH, likely as
a result of recruiting endogenous FLASH (Figure 5B, lane
1). This result is consistent with our previous results show-
ing that FLASH containing the LDLYmotif is essential for
a stable recruitment of the HCC (13).
We assayed immobilized complexes containing ei-
ther functional (with the LDLY motif) or deficient
FLASH (lacking the LDLY motif) for processing activity.
mH2a/2m-3′B substrate labeled at the 5′ end with 32P
was pre-bound in the presence of FLAG-tagged SLBP to
the in vitro assembled core U7 snRNP containing either
the first 139 amino acids of FLASH (139N FLASH) or
61 FLASH (amino acids 62–139), each N-terminally
tagged with GST (Figure 5A). SLBP was used to increase
the efficiency of complex formation, with the FLAG tag
serving to monitor the amount of each purified com-
plex by Western blotting. The pre-mRNA/SLBP/core
U7/FLASH complexes were immobilized on SA beads,
incubated with a nuclear extract to bind the HCC, and
analyzed by Western blotting and silver staining. As
expected, 139N FLASH in contrast to the functionally
incompetent 61 FLASH promoted efficient assembly of
the holo U7 snRNP (Figure 5C). The amount of SLBP
was comparable in both complexes and 61 FLASH was
even more abundant than 139N FLASH, clearly indicating
that the poor binding of the HCC subunits in the presence
of 61 FLASH resulted from deleting the LDLY motif, as
previously shown (13,56).
A fraction of the beads was re-suspended in processing
buffer and divided into small aliquots to test processing
activity of the immobilized complexes. Semi-recombinant
holoU7 snRNP assembled in the presence of 139NFLASH
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Figure 5. Role of FLASH in recruiting polyadenylation factors of the HCC to semi-recombinant holo U7 snRNP and its catalytic activity. (A) Amino acid
sequence of the N-terminal region of FLASH. The essential LDLY motif is boxed and the start points of the 51 and 61 deletions are indicated with
the arrows. The region that binds Lsm11 is underlined. (B) Proteins of mouse nuclear extract that associate with the in vitro assembled core U7 snRNP
either lacking (lane 1) or containing (lane 2) recombinant 51 FLASH. The complexes were immobilized on SA beads via mH2a/2m-3′B pre-mRNA, as
described in the legend for Figure 2A, and bound proteins were visualized by silver staining. (C) In vitro assembled coreU7 snRNPwas bound to either 139N
FLASH or its inactive deletion mutant lacking the LDLY motif, 61. The resultant complexes were next bound in the presence of FLAG-tagged SLBP
to radioactively labeled mH2a/2m-3′B pre-mRNA, immobilized on SA beads and incubated with mouse nuclear extract to reconstitute semi-recombinant
holo U7 snRNP. The presence of the HCC components (symplekin, CPSF100, CPSF73 and CstF64), SLBP and each of the two forms of FLASH, each
N-terminally tagged with GST, was monitored by Western blotting (top panel) and silver staining (bottom panel). (D) Small aliquots of immobilized
processing complexes containing either 139N or 61 FLASH were incubated at 0◦C and 32◦C to evaluate their ability to support endonucleolytic cleavage
of 5′-labeled mH2a/2m-3′B pre-mRNA. (E–I) In vitro assembled core SupU7 snRNP was bound to 61 or 139N FLASH. The complexes were purified
by size exclusion chromatography, analyzed by Western blotting (panel E) and tested for the ability to support processing of H2a/Ys (panel F), SL/Ys
(panel G) and DCP/Ys (panels H and I) in a mouse nuclear extract.
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showed a trace of activity at 0◦C and cleaved nearly 25%
of the immobilized pre-mRNA at 32◦C (Figure 5D, lanes
1 and 2, respectively). No activity at either temperature
was detected for recombinant core U7 snRNP bound to
61 FLASH (Figure 5D, lanes 3 and 4). This experiment
demonstrates that the ability of semi-recombinant holo U7
snRNP to endonucleolytically cleave histone pre-mRNA
depends on the presence of a functional FLASH and sta-
ble recruitment of the HCC.
To confirm that the61 deletionmutant of FLASH does
not support the assembly of semi-recombinant holo U7
snRNP capable of endonucleolytic cleavage, we took ad-
vantage of Ys mutant substrates that are not recognized by
endogenous U7 snRNP due to the presence of a purine-to-
pyrimidine substitution within the HDE (Figure 4C). We
assembled the Sm ring on SupU7/8 snRNA and bound
the resulting core U7 snRNP to GST-tagged 139N FLASH
or 61 FLASH. Both complexes were purified by SEC
and shown by Western blotting using anti-GST and anti-
MBP antibodies to contain similar amounts of FLASH and
Lsm10, respectively (Figure 5E). mH2a/Ys and SL/Ys
served as substrates to monitor the efficiency of endonucle-
olytic cleavage. DCP/Ys RNA was used to test the impor-
tance of FLASH in U7 snRNP-mediated 5′-3′ degradation
of the downstream cleavage product.
mH2a/Ys pre-mRNA contains the stem-loop and was
weakly cleaved by endogenous U7 snRNP due to the pres-
ence of SLBP in the extract (Figure 5F, lane 2), consistent
with previous results (Figure 4D, lane 2). No cleavage dur-
ing the same incubation time was observed for SL/Ys
substrate that lacks the stem-loop and does not bind SLBP
(Figure 5G, lane 2), again in agreementwith previous results
(Figure 4F, lane 2). Core SupU7/8 snRNP bound to the
functionally deficient 61 FLASH showed no major effect
on cleavage of mH2a/Ys (Figure 5F, lane 3) and SL/Ys
pre-mRNAs (Figure 5G, lane 3). Importantly, SupU7/8
snRNP bound to 139N FLASH strongly stimulated cleav-
age of both substrates (lane 4 in Figure 5F and G).
Incubation of the 30-nucleotide DCP/Ys in the mouse
extract yielded a small amount of labeled CMP (Figure
5H, lane 2). The release of the 5′ terminal nucleotide
was blocked by the U7 oligonucleotide (Figure 5H, lane
3), demonstrating that this weak degradation activity de-
pends on endogenous U7 snRNP. The in vitro assembled
SupU7/8 snRNP bound to either 61 or 139N FLASH
strongly stimulated degradation (Figure 5H, lanes 4 and 6)
and this effect was not eliminated by U7 oligonucleotide,
consistent with most of the degradation being mediated by
exogenous SupU7 snRNP (Figure 5H, lanes 5 and 7). Thus,
61 FLASH that fails to stably interact with the HCC and
to promote endonucleolytic cleavage due to the absence of
the LDLYmotif is active in supporting 5′-3′ exonuclease ac-
tivity of CPSF73.
To further confirm that the degradation is promoted
by semi-recombinant holo SupU7/8 snRNP, we used
SupU7, an antisense oligonucleotide complementary to
the 5′ end of SupU7/8 snRNA. In its presence, the release
of labeled 5′ CMP by SupU7/8 snRNP bound to 61
FLASH was inhibited (Figure 5I, line 5) and U7 oligonu-
cleotide that targets endogenous U7 snRNA and weakly
base pairs with SupU7/8 snRNA had no significant ef-
fect (Figure 5I, line 4). We conclude that in agreement with
our previous experiments with endogenousU7 snRNP (56),
binding of fully functional FLASH to Lsm11 is essential for
endonucleolytic cleavage but dispensable for exonucleolytic
degradation of the DCP.
Length suppression by semi-recombinant holo U7 snRNP
In mammalian nuclear extracts, U7 snRNP cleaves his-
tone pre-mRNAs at a fixed distance from the HDE (69).
Based on this finding, we previously created mH2a+4 and
mH2a+12 pre-mRNAs, two variants of mouse histone H2a
(mH2a) pre-mRNA containing a 4- or 12-nucleotide inser-
tion between the stem–loop and HDE (37). Compared to
processing ofWTH2a pre-mRNA, the cleavage site in these
two substrates is shifted further away from the stem, extend-
ing the size of the upstream cleavage products by ∼4 and
∼12 nucleotides, respectively (37).
The shift in the position of the cleavage site in histone pre-
mRNAs containing insertions between the SL and HDE
can be reversed by expressing in vivo an altered U7 snRNA
with similar size complementary insertions incorporated
between the Sm binding site and the 5′ end region (70). We
tested whether the same length suppression can be achieved
in vitro. T7-generated U7 snRNAs containing various in-
sertions or deletions between these two sequence elements
were used to assemble recombinant core U7 snRNPs and
analyzed for the ability to promote length suppression and
cleavage site repositioning in mouse nuclear extracts.
In U7+4 snRNA, we inserted four nucleotides that base
pair with the sequence in histone pre-mRNA located imme-
diately 5′ of the purine core (Figure 6A and B). Otherwise,
U7+4 snRNA had the same sequence as mouse U7 snRNA
(Figure 6A). A SEC-purified complex of core U7+4 snRNP
and 51 FLASH was pre-bound to mH2a+4 or mH2a+12
pre-mRNAs and incubated in a mouse nuclear extract to
recruit the HCC. Note that pre-binding to the substrate
was essential to eliminate the influence of endogenous U7
snRNA, which contains the same 5′ end region and hence
the same substrate specificity as U7+4 snRNA. Processing
of mH2a pre-mRNA in a mouse nuclear extract lacking re-
combinant core U7 snRNP generated an upstream prod-
ucts of 47 nucleotides and the product of mH2a+4 was ex-
tended by 4 nucleotides to 51 nucleotides, consistent with
the molecular ruler mechanism (Figure 6C, compare lanes
1 and 2). Importantly, processing of mH2a+4 pre-mRNA
pre-bound to in vitro assembled core U7+4 snRNP yielded
a 47-nucleotide product, indicative of full length suppres-
sion (Figure 6C, lane 3).We conclude that in vitro assembled
core U7 snRNP containing a 4-nucleotide insertion in its
RNA component restores the correct position of the cleav-
age site in pre-mRNA substrate extended by the same num-
ber of nucleotides, consistent with previous in vivo studies
(70). The same recombinant core snRNP also partially re-
versed the effect of the 12-nucleotide insertion, reducing the
size of the product generated frommH2a+12 pre-mRNAby
∼4 nucleotides (Figure 6C, compare lanes 8 and 9).
To completely eliminate potential interference by endoge-
nous U7 snRNP and the necessity of pre-binding of semi-
recombinant U7 snRNPs and the substrates, we mutated
the AAAGAG purine core in mH2a+4 and mH2a+12 to
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Figure 6. Length suppression by semi-recombinant holo U7 snRNP. (A) Insertions and a deletion in U7 snRNA tested for the ability to reposition the
cleavage site during processing of histone pre-mRNAs. (B) Base pairing between nucleotides inserted in U7 snRNA and nucleotides of histone pre-mRNA
located immediately upstream of the AAAGAG purine core (H2a+4) or its mutated variant UUUCUC (H2a+4/Ys). (C) In vitro processing of indicated
pre-mRNAs in the presence of mouse nuclear extract and indicated recombinant core U7 snRNPs. Only the bottom portion of the gel containing the
upstream cleavage products (cut) is shown. Products that result from shifting the cleavage site as a result of inserting or deleting nucleotides in U7 snRNA
are indicated with the arrows.
UUUCUC. The resultant mH2a+4/Ys and mH2a+12/Ys
pre-mRNAs formwith endogenousU7 snRNAonly aweak
duplex of 8 base pairs (including two GU base pairs) in-
terrupted by one mismatch and are not cleaved in the
mouse nuclear extract (Figure 6C, lanes 4 and 10, respec-
tively). Importantly, cleavage was restored in the presence
of core SupU7 snRNP containing a compensatory muta-
tion in the 5′ end region that increases its base pairing in-
teraction with the mutated HDE. As expected, processing
of mH2a+4/Ys and mH2a+12/Ys pre-mRNAs by SupU7
snRNP yielded the same products as processing ofmH2a+4
andmH2a+12 pre-mRNAs in themouse extract by endoge-
nous U7 snRNP (Figure 6C, compare lanes 2 and 5, and
lanes 8 and 11).
We tested processing of mH2a+4/Ys and mH2a+12/Ys
pre-mRNAs by two additional semi-recombinant U7
snRNPs, SupU7/SL+5 and SupU7-3, containing either
an insertion of five nucleotides or a deletion of 3 nu-
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cleotides between the Sm binding site and the 5′ region (Fig-
ure 6A). In SupU7/SL+5 snRNA, 3 out of 5 added nu-
cleotides base paired with the region inserted into histone
pre-mRNAs (Figure 6B). Note that this chemically synthe-
sized RNA was shortened by deleting the dispensable 3′
terminal stem-loop (SL). The two U7 snRNPs behaved
as expected, moving the cleavage site in mH2a+4/Ys and
mH2a+12/Ys pre-mRNAs either closer (SupU7+5) or fur-
ther away (SupU7-3) from the stem-loop, hence resulting
in a shorter or a longer cleavage product, respectively (Fig-
ure 6C, lanes 6–7 and 12–13). SupU7-3 was only partially
active in shifting the cleavage site in mH2a+4/Ys, with a
relatively small amount of the upstream product being ex-
tended to 54 nucleotides (Figure 6C, lane 7). The major-
ity of pre-mRNA was cleaved at the +4 site, yielding a 51-
nucleotide product, indicative of no cleavage site reposition-
ing. This might be explained by the contribution of SLBP,
which holdsU7 snRNP closer to the stem-loop hence, coun-
terbalancing the effect of the deletion in the U7 snRNA,
which in turn tends to move the cleavage site in the oppo-
site direction, three nucleotides further downstream of the
stem-loop. We also tested SupU7+5n snRNA that contains
a 5-nucleotide insertion unable to form base pairs with the
sequences inserted in mH2a+4/Ys and mH2a+12/Ys pre-
mRNAs (Figure 6A and B). This recombinant core snRNP
was inactive (not shown), consistent with the previous con-
clusion by Scharl and Steitz that effective length suppres-
sion requires that nucleotides inserted in the U7 snRNA
are at least partially complementary to the pre-mRNA sub-
strate (70).
Core U7 snRNP assembled on a spliceosomal Sm binding site
The consensus sequence for the Sm binding site in U7
snRNA, AAUUUGUCU, differs in three positions (un-
derlined) from the consensus AAUUUUUGG Sm binding
site for the spliceosomal snRNAs (7,71,72) (Figure 7A). As
shown in vivo, U7 snRNA containing a spliceosomal Sm
site yielded an snRNP that was inactive in cleaving histone
pre-mRNAs due to the lack of Lsm11 and Lsm10 that were
replaced in the Sm ring by their spliceosomal counterparts,
SmD1 and SmD2 (71,72).
We investigated whether T7-generated U7 snRNA with
the spliceosomal AAUUUUUGG Sm binding site can sup-
port in vitro assembly of the U7-specific Sm ring contain-
ing Lsm10 and Lsm11. Previously, the assembly of the U7-
specific Sm ring onto the spliceosomal Sm site was tested in
vivo, i.e. in the presence of SmD1 and SmD2 whose intra-
cellular concentrations highly exceed those for Lsm10 and
Lsm11. In addition to replacing theU7 Smbinding site with
the spliceosomal sequence, we also made a smaller change
by substituting single cytosine at position 8 to guanosine
(Figure 7A, C–G U7 snRNA). This cytosine and the fol-
lowing uridine (position 9) are invariant in U7 snRNAs
(67) and are extremely rare in the spliceosomal snRNAs (7).
They instead contain guanosine/uridine (position 8) and
guanosine/adenine (position 9) that make cooperative in-
teractions with SmD1/SmD2 and SmE/SmF, respectively
(50) (Figure 7B). The changes within the Sm binding site
weremade in the context of suppressorU7 snRNA (SupU7)
Figure 7. In vitro assembly of the U7-specific ring on a spliceosomal Sm
site. (A) Nucleotide sequence of the U7-specific Sm site (top sequence) and
changes made to generate C-G and spliceosomal-type (Spl) Sm sites (bot-
tom sequences). Mutated nucleotides are indicated with the arrows. (B) In-
teraction between the spliceosomal Sm proteins and individual nucleotides
of the Sm site in U4 snRNA (50). (C) Proteins of the U7-specific Sm ring
bound to the U7, C-G and Spl Sm sites visualized by silver staining (top)
andWestern blotting (bottom). (D) Processing ofSL/Ys pre-mRNA in a
mouse nuclear extract in the presence of 1, 3 and 5 l of peak fraction con-
taining indicated core U7 snRNPs. The arrow denotes the unusual cleav-
age product generated by SupU7 snRNP containing Spl Sm site. (E, F)
Processing of SL/Ys (panel E) and H2a WT/Ys (panel F) pre-mRNAs
in a mouse nuclear extract in the presence of 5 or 2 l of indicated core
SupU7 snRNPs and processing competitors (SL or SupU7).
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capable of recognizing Ys substrates containing the purine-
to-pyrimidine substitution in the HDE (Figure 4C).
The seven recombinant proteins of the U7-specific Sm
ring, including Lsm11 lacking the loop and SmB containing
the C-terminal region (required for Western detection, see
below), were incubated with wild type SupU7 snRNA, or
its two variants containing substitutions within the Sm site,
C–G Sm and Spl Sm (Figure 7A), and the assembled com-
plexes were bound to 51 FLASH and purified by SEC.
The elution profiles indicated that all threeU7 snRNAs pro-
moted the assembly of the U7-specific Sm ring (not shown).
A fraction of each SEC-purified complex was analyzed by
silver staining and showed to contain all Sm subunits of the
ring (Figure 7C). We conclude that the spliceosomal-type
Sm site can nucleate the assembly of a U7-specific Sm ring
in vitro.
We tested 1, 2 and 5 l of the peak SEC fraction (total
150 l) of each core U7 snRNP/FLASH complex for the
ability to support processing in a mouse nuclear extract. As
the substrate, we initially used SL/Ys pre-mRNA, which
due to the lack of the stem-loop and mutations within the
purine core of theHDE is not recognized by endogenousU7
snRNP, yielding no detectable cleavage product in a mouse
nuclear extract (Figure 7D, lane 2). The addition of increas-
ing amounts of core SupU7 snRNP containing thewild type
Smbinding site (U7 Sm) to the nuclear extract resulted in an
increasing efficiency of processing, with the highest amount
used (5 l) yielding ∼40% of the cleavage product during
60 min incubation (Figure 7D, lane 9). Recombinant core
U7 snRNP with the C-G mutation supported correct pro-
cessing, but its activity was weaker, with 5 l of this mutant
being less effective in generating the cleavage product than
1 l of the wild type SupU7 snRNP (Figure 7D, compare
lanes 3 and 10). This lower activity can be at least in part at-
tributed to less efficient ring formation around the C-G Sm
site (Figure 7C, lane 2). U7 snRNA with the Spl Sm site,
in spite of efficiently promoting the ring assembly, gave rise
to a semi-recombinant holo U7 snRNP that in a mouse nu-
clear extract was very inefficient in processing. Only a trace
of the correct 20-nucleotide cleavage product was detected
when 3 and 5 l of this recombinant core U7 snRNP were
added to the nuclear extract (Figure 7D, lanes 8 and 11).
Interestingly, an additional slightly longer product was gen-
erated, suggesting that the U7-specific ring assembled on
the spliceosomal Sm site misguides the CPSF73 endonucle-
ase to a site located further away from the stem–loop. We
tested a different SEC fraction eluted at the beginning of
the peak and observed the same two cleavage products (data
not shown). Both products were eliminated by an antisense
oligonucleotide complementary to the 5′ end region of the
SupU7 snRNA (Figure 7E, lane 7), as were the products
generated by recombinant coreU7 snRNPs containing wild
type and C–G Sm sites (Figure 7E, lanes 3 and 5).
We tested whether the unusual cleavage pattern produced
by recombinant core U7 snRNP containing Spl Sm site will
be also observed with H2aWT/Ys pre-mRNA. In this sub-
strate, the purine-to-pyrimidine mutation was made in the
context of wild type H2a HDE rather than its improved
version, as in case of H2a/Ys. As a result, H2a WT/Ys
pre-mRNA in spite of containing the stem-loop and be-
ing able to interact with SLBP failed to stably recruit en-
dogenous U7 snRNP and yielded no ‘background’ cleavage
product in mouse nuclear extracts (Figure 7F, lane 2). Core
SupU7 snRNP containing U7 Sm site efficiently cleaved
H2a WT/Ys (Figure 7F, lane 3). Cleavage was inhibited in
the presence of SL RNA, consistent with H2a WT/Ys pre-
mRNA requiring SLBP to stably bind U7 snRNP (Figure
7F, lane 4), and by an antisense oligonucleotide comple-
mentary to the 5′ end of SupU7 snRNA (Figure 7F, lane
5). Core SupU7 snRNP containing a spliceosome-type Sm
site (Spl Sm) was again only weakly active in processing,
yielding two products of equal amount: the correct prod-
uct and a new product longer by 3–4 nucleotides, with the
generation of each being sensitive to the presence of the SL
RNA and anti-U7 oligonucleotide (Figure 7F, lanes 6–8).
These results strongly suggest that the Sm site inU7 snRNA
is important for determining the site of cleavage in histone
pre-mRNA.
DISCUSSION
U7 snRNP is a multi-subunit endonuclease that cleaves
replication-dependent histone pre-mRNAs 4–5 nucleotides
downstream of a highly conserved stem-loop structure, gen-
erating mature histone mRNAs without a poly(A) tail (24).
In the simplest core form,U7 snRNP consists ofU7 snRNA
and a heptameric ring containingLsm10 andLsm11 instead
of the spliceosomal subunits SmD1 and D2 (6). Lsm11
binds FLASH (11), forming a platform for the recruitment
of the Histone pre-mRNA Cleavage Complex (HCC), an
assembly of 4 major polyadenylation factors: symplekin,
CPSF100, CPSF73 and CstF64 (15), with CPSF73 acting
as the 3′ endonuclease (23,38,73). We refer to this catalyti-
cally active form as holo U7 snRNP.
Detailed biochemical, structural and functional studies
on endogenous holoU7 snRNP have been limited by its low
concentration in animal cells (10,71). As a first step toward
bypassing this limitation, we assembled core U7 snRNP us-
ing in vitro generated U7 snRNA and seven recombinant
proteins of the U7-specific Sm ring. Analysis by electron
microscopy revealed that assembled core U7 snRNP has a
shape of a ring with an opening inside. A short tail attached
to the ring is also visible and it likely represents the long
3′ terminal stem-loop of U7 snRNA. Overall, this image is
highly reminiscent of the structure of core U1, U2, U4 and
U5 snRNPs determined by electron microscopy and/or X-
ray crystallography (46,48,74–76), strongly arguing that U7
snRNP in spite of containing two unique subunits, Lsm10
and Lsm11, and a unique Sm binding site in the U7 snRNA
assembles into a similar heptameric donut-shaped core do-
main.
Biochemical and functional analysis of semi-recombinant
holo U7 snRNP
For biochemical and functional studies, recombinant core
U7 snRNP bound to FLASH was incubated with a mouse
nuclear extract to recruit the endogenous HCC. The semi-
recombinant holo U7 snRNP reconstituted in this man-
ner was active in processing and contained the same sub-
set of polyadenylation factors that bind endogenous U7
snRNP: symplekin, CPSF100, CPSF73 andCstF64 (15,34).
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All these proteins were barely detectable if the in vitro as-
sembled core U7 snRNP lacked recombinant FLASH, or
was complexed with the 61 FLASH mutant that is un-
able to recruit the HCC due to the absence of the essential
LDLY motif (amino acids 55–58). Altogether, these results
provided evidence that the core U7 snRNP composed of re-
combinant U7 snRNA and Sm subunits gives rise to an ac-
tive semi-recombinant holo U7 snRNP and confirmed our
previous data that binding of the endogenous HCC to core
U7 snRNPdepends on the presence of a functional FLASH
containing the LDLY motif.
U7 snRNP reconstituted in the presence of 61 FLASH
(lacking the LDLY motif at positions 55–58), while being
unable to stably recruit the HCC and endonucleolytically
cleave histone pre-mRNAs, displayed a robust 5′-3′ exonu-
clease activity that degrades the downstream cleavage prod-
uct. This result provides a strong argument that these two
enzymatic activities of CPSF73 are mechanistically distinct
and confirms our previous conclusion based on using a
different experimental approach that stable binding of the
HCC to the core U7 snRNP is critical for CPSF73 to act as
an endonuclease but not as a 5′-3′ exonuclease (13,56).
To assemble core U7 snRNP, we used U7 snRNA that
was either chemically synthesized or generated by T7 tran-
scription, yielding in each case a catalytically active semi-
recombinant holo U7 snRNP. Thus, the presence of addi-
tional nucleotides at the 5′ and 3′ ends of U7 snRNA that
result from T7 transcription does not affect the activity of
U7 snRNP. These results also argue that the function of U7
snRNA in processing does not depend on the presence of
essential nucleotide modifications or the cap structure. Pre-
vious studies demonstrated that U2 snRNP reconstituted
from T7-generated U2 snRNA failed to support in vitro
splicing due to the absence of essential pseudouridine and
2′O-methyl modifications within the 5′ end region (77,78).
In contrast, in vitro generated U5 snRNA, similarly to U7
snRNA, yielded a functional snRNP (77).
All known U7 snRNAs contain an extensive 3′ terminal
stem-loop structure that is not conserved at the sequence
level (4,79). Truncations of the stem from 11 to 6 base pairs
or removal of the entire 3′ terminal stem-loop yielded func-
tional U7 snRNP, indicating that this part of U7 snRNA
has no direct role in processing. Previous studies demon-
strated that U7 snRNAs lacking a stable stem at the 3′ end
do not assemble into active U7 snRNPs in Xenopus oocytes
(4,68). Clearly, the 3′ terminal stem-loop fulfills a number of
essential functions in vivo, being important for 3′ end pro-
cessing of the U7 snRNA precursor and transcriptional ter-
mination, stabilizing mature U7 snRNA against 3′ exonu-
cleases and increasing the efficiency of Sm ring assembly via
the SMN complex (44,80,81).
Of the seven recombinant proteins used to assemble ac-
tive U7-specific Sm ring in vitro, SmE, SmF, SmG, SmB
and SmD3 were expressed in bacteria. Thus, the function
of these Sm subunits in processing of histone pre-mRNAs
does not require essential post-translational modifications.
Lsm10 and Lsm11 were expressed in insect cells using the
baculovirus system. These two subunits are poorly con-
served between vertebrates and invertebrates and hence
are also unlikely to contain any modifications essential for
processing. SmE, SmF, SmG, SmD3 and Lsm10 were full
length. In some experiments, SmB lacked the entire unstruc-
tured C-terminal region (amino acids 96–324) and Lsm11
lacked amino acids 211–332 encompassing a large loop be-
tween the Sm1 and Sm2 motifs. Semi-recombinant holo
U7 snRNPs reconstituted using these two truncated sub-
units were functionally indistinguishable from those that
contained full length proteins. The deleted regions may be
required for recruiting the SMN complex in the cytoplasm,
other essential in vivo functions, or as in case of SmB, for
splicing-related functions. These experiments illustrate the
utility of our new system and how it can be used for map-
ping regions in the Sm ring that are essential for in vitro pro-
cessing of histone pre-mRNAs.
Our studies demonstrated that the semi-recombinant
holo U7 snRNP, when assayed in nuclear extracts, ef-
ficiently cleaves pre-mRNA substrates independently of
SLBP, mimicking the in vitro behavior of endogenous U7
snRNP. Surprisingly, semi-recombinant holo U7 snRNP
purified by UV-elution (15,62) and tested in a reconsti-
tuted reaction displayed a stronger dependence on SLBP
in cleaving the same substrate. It is possible that nuclear
extracts contain additional auxiliary factors that can par-
tially substitute for the function of SLBP, facilitating bind-
ing of U7 snRNP to the HDE and/or presenting the sub-
strate for cleavage. Based on our preliminary experiments,
this function is unlikely to be mediated by hnRNP Q, a
relatively abundant RNA binding protein frequently found
to associate in mouse nuclear extracts with the 3′ end re-
gion of histone H2a pre-mRNAs (15,34,53). Further stud-
ies are required to test potential involvement of other can-
didate hnRNPs and their multiple splice variants in U7-
dependent processing. It is also possible that the unexpected
dependence of the reconstituted in vitro processing reaction
on SLBP results from partial damage of semi-recombinant
holo U7 snRNP during the UV-elution step, or other tech-
nical aspects of the method, rather than from the absence
of an auxiliary factor.
Changing substrate and cleavage specificities of semi-
recombinant holo U7 snRNP
Substrate specificity of U7 snRNP is provided by the
5′ end region of U7 snRNA, which base pairs with the
HDE of histone pre-mRNA. We tested whether mouse
semi-recombinant holo U7 snRNP can cleave histone
pre-mRNAs containing mutations within the HDE and
whether the effect of these mutations can be suppressed
by compensatory changes in U7 snRNA. Previously, the
same approach was used in vivo to demonstrate that sub-
strate recognition by U7 snRNP involves base pairing in-
teraction between the 5′ end of U7 snRNA and the HDE
(35,64,65). We replaced the AAAGAG purine core in the
HDE of mH2a pre-mRNA with UUUCUC, reducing the
number of base pairs formed with the mouse U7 snRNA
and severely inhibiting processing in mouse nuclear ex-
tracts. Semi-recombinant SupU7 snRNP containing a com-
pensatory mutation within the 5′ end of U7 snRNA (CU-
CUUU to AAAGAG) restored both the base pairing po-
tential with the mutant pre-mRNA and its efficient process-
ing. Collectively, these results clearly demonstrate that the
substrate specificity of semi-recombinant U7 snRNP is de-
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termined by the sequence of the 5′ end region of the U7
snRNAcomponent,mimicking the behavior of endogenous
U7 snRNP.
Mouse nuclear extracts are unable to process Drosophila
histone pre-mRNAs due to incompatibility of their HDEs
with the mouse U7 snRNA. We tested whether mouse
U7 snRNA can be reprogrammed to recognize Drosophila-
specific histone pre-mRNAs in mouse nuclear extracts. By
substituting the 5′ end region of mouse U7 snRNA with a
sequence of 19 nucleotides complementary to the HDE of
Drosophila histone H3 pre-mRNA, we assembled a core U7
snRNP that when added to a mouse nuclear extract recon-
stituted holo U7 snRNP capable of efficiently cleaving this
pre-mRNA.
Cleavage of histone pre-mRNAs in mammalian nuclear
extracts occurs at a fixed distance from the HDE, the site of
U7 snRNP binding (69). Insertions that increase the spac-
ing between the stem-loop and the HDE result in repo-
sitioning of the cleavage site to maintain the same dis-
tance from the HDE. This effect can be reversed by semi-
recombinant holo U7 snRNP assembled on U7 snRNA
containing a corresponding insertion between the Sm site
and the 5′ end region. Thus, U7 snRNP reconstituted from
both recombinant and endogenous components is also ca-
pable of length suppression, mimicking the activity of U7
snRNPs assembled in vivo (70). As previously concluded
(70), our in vitro results indicate that the sequence inserted
in the U7 snRNA of the in vitro reconstituted U7 snRNP
must be at least partially complementary to the pre-mRNA.
Consistent with themechanism of length suppression, semi-
recombinant U7 snRNP assembled on U7 snRNA with a
short deletion between the Sm site and the 5′ end causes the
opposite effect; the cleavage site moves further away from
the stem–loop, enhancing rather than suppressing the effect
of insertions in the pre-mRNAsubstrate. Altogether, our re-
sults indicate that by simply changing the sequence of the 5′
end region in U7 snRNA and its distance to the Sm bind-
ing site, the semi-recombinant U7 snRNP can be converted
into an endoribonuclease of desired substrate and cleavage
specificities.
The U7-specific Sm binding site plays an important role in
determining the cleavage site
The AAUUUUUGA sequence of the human U4 Sm site is
sufficient to assemble seven spliceosomal Sm proteins into
a heptameric Sm ring in vitro (46,82). According to recently
re-refined structures, each of the first seven nucleotides of
this sequence interacts with a single Sm subunit of the ring
in the following register: SmF, SmE, SmG, SmD3, SmB,
SmD1 and SmD2. The penultimate guanosine (position 8)
and the terminal adenosine (position 9) are recognized co-
operatively by SmD1 and SmD2, and SmE and SmF, re-
spectively (50). The same mode of interaction is used by the
seven spliceosomal Sm proteins to recognize the AAUU-
UGUGG Sm site from U1 snRNA, with the exception that
SmD1 binds the guanosine at position 6 rather than uridine
present in U4 snRNA (50).
The U7-specific Sm site, AAUUUGUCU, differs from
the AAUUUUUGG spliceosomal consensus, with the ter-
minal CUdinucleotide being virtually invariable inU7 snR-
NAs and never found at this position in the spliceosomal
snRNAs (7). The in vivo expression of a mutant U7 snRNA
containing the spliceosomal Sm site resulted in the incorpo-
ration of SmD1 and SmD2 instead of Lsm10 and Lsm11,
yielding core U7 snRNP that failed to support process-
ing of histone pre-mRNAs (9,72). In vitro, in the absence
of the SmD1 and SmD2 proteins, the same mutant U7
snRNA promoted the assembly of a stable Sm ring contain-
ing Lsm10 and Lsm11, allowing for the first time functional
studies on the resultant chimeric coreU7 snRNP. Strikingly,
this core U7 snRNP displayed only a weak processing ac-
tivity when added to mouse nuclear extracts, inefficiently
cleaving histone pre-mRNA at both the correct site and a
new site located 3–4 nucleotides further downstream. Cleav-
age at this downstream site was never observed for endoge-
nous U7 snRNP or the recombinant U7 snRNP contain-
ing the wild type Sm site. While the molecular basis for this
altered cleavage activity is unknown, one possibility is that
binding of Lsm10 andLsm11 to the spliceosomal Sm site af-
fects the overall geometry of the U7-specific Sm ring, result-
ing in misalignment of the CPSF73 endonuclease with the
substrate. This possibility will be addressed by future struc-
tural studies that will take advantage of the successfully as-
sembled and functionally competent core U7 snRNP de-
scribed in this report.
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